AOD-9604 for Fat Loss Research 5mg
Targets Stubborn Fat Deposits
$35.00
* This product is strictly for laboratory research use only and must not be used for human consumption, medical treatments, or any other non-research purposes.
What is AOD-9604
AOD-9604, often called the "fat-burning peptide," is a modified fragment of human growth hormone (HGH) developed to stimulate lipolysis (fat breakdown). Unlike traditional HGH, AOD-9604 specifically targets fat loss without affecting blood glucose levels. Researchers are investigating its potential for reducing stubborn body fat, particularly around the abdominal area.
Mechanism of Action:
AOD-9604 activates specific pathways in the body related to fat metabolism. By stimulating the breakdown of fat and inhibiting new fat formation, AOD-9604 focuses on adipose (fat) tissue, making it an ideal candidate for studies on weight management and metabolic health.
Potential Benefits:
Fat Reduction: Targets fat stores in areas resistant to diet and exercise.
Metabolic Support: Enhances metabolic processes related to fat burning.
No Blood Sugar Impact: Designed to avoid the effects of HGH on glucose levels.
Potential Anti-Inflammatory Effects: Preliminary studies suggest it may reduce inflammation in adipose tissues.
Current Research Areas:
Obesity and Weight Loss: AOD-9604 is a primary peptide of interest in studies focusing on obesity and body fat reduction.
Metabolic Health: Researchers are exploring its effects on metabolism and overall energy expenditure.
Anti-Inflammation in Fat Tissues: Studies indicate potential anti-inflammatory benefits in adipose tissue.
Dosage and Administration:
Common Research Dosage: 0.25 mg (250 mcg) daily, injected subcutaneously.
Timing: Typically administered in the morning to align with daily metabolic processes.
Safety and Potential Side Effects:
Injection Site Reactions: Some users report mild irritation or redness.
Headache and Mild Nausea: Rare but possible with higher doses.
Additional Research References:
PubMed: Research on AOD-9604 and fat loss (PubMed).
ScienceDirect: Studies on peptides in obesity treatment (ScienceDirect).